DrugPatentWatch Database Preview
Radiomedix Company Profile
» See Plans and Pricing
What is the competitive landscape for RADIOMEDIX, and what generic alternatives to RADIOMEDIX drugs are available?
RADIOMEDIX has one approved drug.
There are two US patents protecting RADIOMEDIX drugs.
There are five patent family members on RADIOMEDIX drugs in six countries.
Summary for Radiomedix
| International Patents: | 5 |
| US Patents: | 2 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Radiomedix
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Radiomedix | DETECTNET | copper dotatate cu-64 | SOLUTION;INTRAVENOUS | 213227-001 | Sep 3, 2020 | RX | Yes | Yes | 10,159,759 | Start Trial | Start Trial | ||||
| Radiomedix | DETECTNET | copper dotatate cu-64 | SOLUTION;INTRAVENOUS | 213227-001 | Sep 3, 2020 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| Radiomedix | DETECTNET | copper dotatate cu-64 | SOLUTION;INTRAVENOUS | 213227-001 | Sep 3, 2020 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Radiomedix Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Spain | 2732823 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2013029616 | Start Trial |
| Denmark | 2750717 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
